EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sodium Butyrate Alleviates IBD by Modulating SIRT1-Involved Ferroptosis and Inhibition of Macrophage Ferroptosis

Nachuan Chen, Shaofeng Luo, Xin Zhou, Boren Zhu, Yingyin Liu, Huaxing He, Shunli Luo, Suxia Sun

Nutrients · 11.02.2026 · 18 (4) · 598

DOI: 10.3390/nu18040598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 11.02.2026. Verfasst von Nachuan Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical…. Hauptthemen laut MEDLINE: Ferroptosis, Macrophages, Butyric Acid, Sirtuin 1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Nature Science Foundation of Guangdong Province, the National College Student Innovation and Entrepreneurship Training Program, the Research Project of Hunan Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), severely affects patients’ quality of life. Sodium butyrate (NaB) has been reported to improve IBD manifestations, although its underlying mechanisms remain incompletely understood.

Methods

An IBD mouse model was induced with 3% (w/v) dextran sulfate sodium (DSS). Mice were administered NaB (500 mg/kg, gavage), 5-aminosalicylic acid (5-ASA,150 mg/kg, gavage), or the ferroptosis inhibitor ferrostatin-1 (Fer-1, intraperitoneal injection). Western blotting (WB) and real-time quantitative PCR (RT-qPCR) were performed to evaluate ferroptosis-related molecules and target pathway components. Immunofluorescence staining was used to assess ferroptosis in macrophages preliminarily.

Results

NaB alleviated clinical symptoms of IBD in mice, including mitigation of body weight loss, restoration of colon length, reduction in disease activity index (DAI), decreased spleen index, and protection of the intestinal barrier. In addition, compared with the DSS model group, NaB downregulated ACSL4 and upregulated GPX4 and SLC7A11, indicating an inhibitory effect on ferroptosis. WB results showed that SIRT1 expression was enhanced in the DSS + NaB group. In addition, immunofluorescence staining demonstrated that compared with the DSS group, GPX4 expression was increased in macrophages in the DSS + NaB group.

Conclusions

NaB alleviates IBD by modulating SIRT1-associated signaling molecules and inhibiting ferroptosis, including inhibiting macrophage ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisMacrophagesButyric AcidSirtuin 1Inflammatory Bowel DiseasesAnimalsMiceDisease Models, AnimalDextran SulfateMaleMice, Inbred C57BL

Stichwörter der Autor:innen

IBDSIRT1ferroptosismacrophage ferroptosissodium butyrate

Substanzen

Butyric AcidSirtuin 1Sirt1 protein, mouseDextran Sulfate

Autor:innen und Institutionen

  • Department of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.
  • Department of Food Hygiene and Nutrition, College of Laboratory Medicine, Hunan University of Medicine, Huaihua 418000, China.

Förderung

  • the Nature Science Foundation of Guangdong Province
  • the National College Student Innovation and Entrepreneurship Training Program
  • the Research Project of Hunan Provincial Department of Education
  • the Hunan Provincial Natural Science Foundation Regional Joint Fund Project
  • Nature Science Foundation of Guangdong Province
  • Hunan Provincial Natural Science Foundation Regional Joint Fund Project
  • National College Student Innovation and Entrepreneurship Training Program
  • Research Project of Hunan Provincial Department of Education

Zitieren

APA

Chen, N., Luo, S., Zhou, X., Zhu, B., Liu, Y., He, H., Luo, S., & Sun, S. (2026). Sodium Butyrate Alleviates IBD by Modulating SIRT1-Involved Ferroptosis and Inhibition of Macrophage Ferroptosis. Nutrients, 18(4), 598. https://doi.org/10.3390/nu18040598

Vancouver

Chen N, Luo S, Zhou X, Zhu B, Liu Y, He H, et al. Sodium Butyrate Alleviates IBD by Modulating SIRT1-Involved Ferroptosis and Inhibition of Macrophage Ferroptosis. Nutrients. 2026;18(4):598. doi:10.3390/nu18040598

BibTeX
@article{Chen2026,
  author = {Chen, Nachuan and Luo, Shaofeng and Zhou, Xin and Zhu, Boren and Liu, Yingyin and He, Huaxing and Luo, Shunli and Sun, Suxia},
  title = {Sodium Butyrate Alleviates IBD by Modulating SIRT1-Involved Ferroptosis and Inhibition of Macrophage Ferroptosis},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {598},
  doi = {10.3390/nu18040598}
}
Kostenlos starten →